CCC Knowledge Series on Labour Codes

CCC Knowledge Series on Labour Codes : Industry Readiness & Implementation Roadmap– Understanding the Codes. Preparing for Implementation. About the Knowledge Series The Consultants Consortium of Chennai (CCC) proposes a dedicated Knowledge Series on Labour Codes to help organisations, professionals and… 

FUTURE ENERGY SUMMIT 2026

FUTURE ENERGY SUMMIT 2026 – Energy Security, Sustainability & Investment Opportunities @ Chennai – Sep 18,2026 (Friday) – 9 30 am to 5 30 pm Future Energy Summit 2026 Exploring Alternative Energy Technologies for Energy-Secure Businesses Global geopolitical developments, energy… 

Medical Device Consultant Certification Scheme

Join the National Stakeholder Consultation on the Draft Medical Device Consultant Certification Scheme (MDCCS) announced by LSSSDC, on July 20th 2026, Monday – 4 00 pm – 05 30 pm IST – Online Mode Joint Online Stakeholder Meeting: Discussion on… 

Update – India Food Safety Conclave 2026

India Food Safety Conclave 2026 – 7th of August 2026 @ Bengaluru The India Food Safety Conclave 2026 is happening on the 7th of August at the Sheraton Hotel, Brigade Gateway, Bangalore. The event’s objective is to bring together practitioners,… 

Regulatory Alert – CDSCO

CDSCO Suspends HCG Bengaluru Ethics Committee for 2 Years Over Critical Clinical Trial Lapses

India’s top drug regulator, the CDSCO, has slapped a 24-month suspension on the Ethics Committee of the HCG Bangalore Institute of Oncology. Following a risk-based inspection, regulators uncovered severe compliance failures, including delayed reporting of serious adverse events (including participant deaths), glaring conflicts of interest, and inadequate medical management for trial subjects. While the committee is barred from approving new studies, it must continue monitoring active trials under strict regulatory supervision. Read on for a deep dive into the findings and what this means for clinical trial oversight in India.